CN107835800B - 环状化合物 - Google Patents

环状化合物 Download PDF

Info

Publication number
CN107835800B
CN107835800B CN201680040064.1A CN201680040064A CN107835800B CN 107835800 B CN107835800 B CN 107835800B CN 201680040064 A CN201680040064 A CN 201680040064A CN 107835800 B CN107835800 B CN 107835800B
Authority
CN
China
Prior art keywords
mixture
compound
group
ethyl
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201680040064.1A
Other languages
English (en)
Chinese (zh)
Other versions
CN107835800A (zh
Inventor
小林俊威
斋藤盛久
和田康史
奈良洋
根来伸行
加藤泰祐
山嵜将司
田中崇裕
北本直美
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd
Publication of CN107835800A publication Critical patent/CN107835800A/zh
Application granted granted Critical
Publication of CN107835800B publication Critical patent/CN107835800B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/12—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/46—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN201680040064.1A 2015-05-08 2016-05-06 环状化合物 Active CN107835800B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2015-095817 2015-05-08
JP2015095817 2015-05-08
PCT/JP2016/064204 WO2016182036A1 (en) 2015-05-08 2016-05-06 Cyclic compounds

Publications (2)

Publication Number Publication Date
CN107835800A CN107835800A (zh) 2018-03-23
CN107835800B true CN107835800B (zh) 2019-11-26

Family

ID=56132991

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201680040064.1A Active CN107835800B (zh) 2015-05-08 2016-05-06 环状化合物

Country Status (11)

Country Link
US (3) US9611244B2 (cg-RX-API-DMAC10.html)
EP (1) EP3294706B1 (cg-RX-API-DMAC10.html)
JP (1) JP6718884B2 (cg-RX-API-DMAC10.html)
CN (1) CN107835800B (cg-RX-API-DMAC10.html)
AR (1) AR104539A1 (cg-RX-API-DMAC10.html)
CA (1) CA2985325C (cg-RX-API-DMAC10.html)
EA (1) EA033083B1 (cg-RX-API-DMAC10.html)
ES (1) ES2772703T3 (cg-RX-API-DMAC10.html)
TW (1) TW201704206A (cg-RX-API-DMAC10.html)
UY (1) UY36675A (cg-RX-API-DMAC10.html)
WO (1) WO2016182036A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9611244B2 (en) * 2015-05-08 2017-04-04 Takeda Pharmaceutical Company Limited Cyclic compounds
RU2742337C2 (ru) 2016-09-09 2021-02-04 Такеда Фармасьютикал Компани Лимитед Циклическое соединение
FR3095755A1 (fr) * 2019-05-10 2020-11-13 Balmes Transplantation Nouveaux médicaments cytoprotecteurs
CN114425054A (zh) * 2022-01-20 2022-05-03 中国人民解放军军事科学院军事医学研究院 一种蛋白酶体抑制剂Bortezomib在抗辐射损伤中的用途

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1374946A (zh) * 1999-08-06 2002-10-16 武田药品工业株式会社 取代的芳香环化合物及其制备方法和用途
CN1658863A (zh) * 2002-04-08 2005-08-24 武田药品工业株式会社 重症脓毒病预防治疗药物
JP2008260760A (ja) * 2007-03-12 2008-10-30 Daiichi Sankyo Co Ltd 置換シクロアルケン誘導体を含有する医薬組成物
CN101309900A (zh) * 2005-09-14 2008-11-19 第一三共株式会社 取代环烯烃衍生物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1063228T5 (da) 1998-03-09 2009-06-15 Takeda Pharmaceutical Cycloalkenderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf
JP2004002370A (ja) * 2002-04-08 2004-01-08 Takeda Chem Ind Ltd 重症セプシス予防治療剤
US20100135908A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Delivery devices for modulating inflammation
SG10201503402XA (en) 2010-01-27 2015-06-29 Takeda Pharmaceutical Compounds for suppressing a peripheral nerve disorder induced by an anti-cancer agent
US9611244B2 (en) * 2015-05-08 2017-04-04 Takeda Pharmaceutical Company Limited Cyclic compounds

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1374946A (zh) * 1999-08-06 2002-10-16 武田药品工业株式会社 取代的芳香环化合物及其制备方法和用途
CN1658863A (zh) * 2002-04-08 2005-08-24 武田药品工业株式会社 重症脓毒病预防治疗药物
CN101309900A (zh) * 2005-09-14 2008-11-19 第一三共株式会社 取代环烯烃衍生物
JP2008260760A (ja) * 2007-03-12 2008-10-30 Daiichi Sankyo Co Ltd 置換シクロアルケン誘導体を含有する医薬組成物

Also Published As

Publication number Publication date
US9828357B2 (en) 2017-11-28
CA2985325C (en) 2023-09-26
UY36675A (es) 2016-12-30
EA201792469A1 (ru) 2018-06-29
ES2772703T3 (es) 2020-07-08
CN107835800A (zh) 2018-03-23
EA033083B1 (ru) 2019-08-30
WO2016182036A1 (en) 2016-11-17
US20160326133A1 (en) 2016-11-10
US20170066737A1 (en) 2017-03-09
US9533966B2 (en) 2017-01-03
CA2985325A1 (en) 2016-11-17
EP3294706A1 (en) 2018-03-21
JP6718884B2 (ja) 2020-07-08
AR104539A1 (es) 2017-07-26
JP2018516875A (ja) 2018-06-28
US20160326102A1 (en) 2016-11-10
EP3294706B1 (en) 2019-12-04
BR112017023818A2 (pt) 2018-07-31
TW201704206A (zh) 2017-02-01
US9611244B2 (en) 2017-04-04

Similar Documents

Publication Publication Date Title
CN108026088B (zh) 用作hdac抑制剂的噁二唑衍生物
ES2777123T3 (es) Pirazol para el tratamiento de trastornos autoinmunes
US10406146B2 (en) Heterocyclic compound
US10357484B2 (en) Heterocyclic compound
JP6787913B2 (ja) 複素環化合物
CA2954042A1 (en) Heterocyclic compounds and their use as retinoid-related orphan receptor (ror) gamma-t inhibitors
WO2015146929A1 (ja) 複素環化合物
US10548877B2 (en) Aromatic ring compound
CN107835800A (zh) 环状化合物
WO2016047678A1 (ja) 複素環化合物
WO2015146928A1 (ja) 複素環化合物
WO2016181894A1 (ja) 環状化合物
BR112017023818B1 (pt) Composto, e, medicamento

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant